Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-09-06
1998-08-25
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514826, 514558, 514559, 514560, A61K 3119, A61K 3122
Patent
active
057983887
ABSTRACT:
A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces the undesired inflammatory response and is an antioxidant. The inflammatory response mediator may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response are also disclosed.
REFERENCES:
patent: 3235583 (1966-02-01), Edmunds et al.
patent: 3920835 (1975-11-01), Van Scott et al.
patent: 3984556 (1976-10-01), Van Scott et al.
patent: 4105783 (1978-08-01), Yu et al.
patent: 4158057 (1979-06-01), Stanko
patent: 4197316 (1980-04-01), Yu et al.
patent: 4232002 (1980-11-01), Nogrady
patent: 4234599 (1980-11-01), Van Scott et al.
patent: 4246261 (1981-01-01), Van Scott et al.
patent: 4294852 (1981-10-01), Wildnauer et al.
patent: 4351835 (1982-09-01), Stanko
patent: 4363815 (1982-12-01), Yu et al.
patent: 4415576 (1983-11-01), Stanko
patent: 4416982 (1983-11-01), Tauda et al.
patent: 4521375 (1985-06-01), Houlsby
patent: 4548937 (1985-10-01), Stanko
patent: 4645764 (1987-02-01), Stanko
patent: 4663166 (1987-05-01), Veech
patent: 4696917 (1987-09-01), Lindstrom et al.
patent: 4725586 (1988-02-01), Lindstrom et al.
patent: 4734276 (1988-03-01), Ziegler
patent: 4812479 (1989-03-01), Stanko
patent: 5256697 (1993-10-01), Miller et al.
patent: 5296370 (1994-03-01), Martin et al.
patent: 5480909 (1996-01-01), Stanko
patent: 5536751 (1996-07-01), Bunger
patent: 5633285 (1997-05-01), Martin
patent: 5641814 (1997-06-01), Martin
patent: 5646190 (1997-07-01), Martin
patent: 5648380 (1997-07-01), Martin
patent: 5658957 (1997-08-01), Martin
O'Donnell-Tormey, et al., "Secretion of Pyruvate", J. Exp. Med., pp. 500-514 (1987).
Puschmann, et al., Arzneim-Forsh./Drug Res. 33(1), pp. 415416(1983).
Salahudeen, et al.,"Hydrogen Peroxide -Induced Renal Injury", J. Clin. Invest., 88, pp. 1886-1893 (1991).
Schwartz, et al., Antagonism of Cyanide Intoxication with Sodium Pyruvate, Toxicol. and Applied Pharmacology, 50, pp. 437-442 (1979).
Chemical Abstracts AN 1995:669969, Housset, "Free Radicals and Lung Injury", Jan. 1994.
Chemical Abstracts AN 1991:490010, Barnes, "Reactive Oxygen Species and airway inflammation.", Jan. 1990.
Cellular Sciences Inc.
Gaglia, Jr. Charles A.
MacMillan Keith D.
LandOfFree
Method and composition for treating mammalian diseases caused by does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for treating mammalian diseases caused by, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for treating mammalian diseases caused by will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36730